Product image of Niquitinminis Menthe Édulcoré À L'acésulfame Potassique Et Au Sucralose (Nicotine Resinate) supplied by GNH India

Niquitinminis Menthe Édulcoré À L'acésulfame Potassique Et Au Sucralose

Active Ingredient:
Nicotine Resinate
Origin:
EU

Niquitinminis Menthe Édulcoré À L'acésulfame Potassique Et Au Sucralose (Nicotine Resinate)

Nicotine resinate, the active ingredient in Niquitinminis Menthe Édulcoré À L'acésulfame Potassique Et Au Sucralose, is a nicotine‑based compound presented as an oral formulation for systemic use. It is primarily investigated for its role in nicotine replacement and dependence management.
GNH India supplies Niquitinminis Menthe Édulcoré À L'acésulfame Potassique Et Au Sucralose as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Manufacturer / TM Owner

Laboratoire Perrigo France

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Nicotine resinate is used in contexts related to nicotine dependence and research on nicotine pharmacology.

  • Smoking cessation: assists adults attempting to quit tobacco by providing a controlled nicotine source.
  • Nicotine dependence: helps reduce withdrawal symptoms in individuals with established nicotine addiction.
  • Clinical research: serves as a standardized nicotine source in pharmacological studies evaluating nicotine‑related pathways.

How It Works

  • Nicotine resinate dissociates to release nicotine, which binds to neuronal nicotinic acetylcholine receptors (nAChRs). Activation of these ligand‑gated ion channels leads to increased neurotransmitter release (dopamine, norepinephrine, acetylcholine) and modulation of central reward pathways, thereby attenuating withdrawal and craving sensations associated with nicotine dependence.

Side Effects

Nicotine resinate may be associated with a range of adverse reactions.

Common Side Effects

  • Nausea: mild to moderate stomach upset.
  • Headache: transient tension‑type headaches.
  • Dizziness: sensation of light‑headedness.
  • Insomnia: difficulty initiating or maintaining sleep.
  • Gastrointestinal discomfort: abdominal cramping or diarrhea.
  • Increased heart rate: mild tachycardia.

Serious or Rare Side Effects

  • Severe allergic reaction: rash, swelling, or anaphylaxis.
  • Hypertension: marked elevation of blood pressure.
  • Cardiac arrhythmia: irregular heart rhythm.
  • Seizures: convulsive episodes in susceptible individuals.
  • Respiratory distress: difficulty breathing.
  • Persistent vomiting: leading to dehydration.

Precautions & Warnings

When considering nicotine resinate, several safety measures are recommended.

  • Cardiovascular disease: monitor blood pressure and heart rate closely.
  • Pregnancy: avoid use unless clearly indicated by a healthcare professional.
  • Breastfeeding: assess risk versus benefit before administration.
  • Concomitant stimulant use: evaluate for additive sympathomimetic effects.
  • Renal or hepatic impairment: adjust monitoring as needed.
  • Store at ambient temperature: keep below 25°C, retain in original packaging, protect from moisture and direct sunlight.

Avoid Interactions

Nicotine resinate can interact with other medicines, requiring attention to potential effects.

Major Interactions (Avoid)

  • Monoamine oxidase inhibitors (MAOIs): risk of hypertensive crisis.
  • Beta‑blockers: may blunt nicotine‑induced tachycardia, complicating cardiovascular assessment.

Moderate Interactions (Monitor Closely)

  • Antidiabetic agents: nicotine may affect glucose metabolism.
  • Oral contraceptives: potential reduction in efficacy.
  • Warfarin: possible alteration of anticoagulant effect.
  • Antidepressants (SSRIs): monitor for increased nervous system stimulation.
  • Caffeine: additive stimulant effects may increase jitteriness.

Frequently Asked Questions

Niquitinminis Menthe Édulcoré contains nicotine resinate and is primarily used to support smoking cessation and to reduce nicotine withdrawal symptoms in individuals with nicotine dependence. It may also be employed in clinical research to study nicotine‑related pharmacology.

Nicotine resinate releases nicotine, which binds to neuronal nicotinic acetylcholine receptors. This activation triggers the release of neurotransmitters such as dopamine and norepinephrine, modulating reward pathways and alleviating cravings associated with nicotine withdrawal.

The appropriate dose of nicotine resinate is determined by the prescribing healthcare professional based on the individual’s clinical situation, nicotine dependence level, and treatment goals. No fixed dosing regimen is provided here.

Use of nicotine resinate during pregnancy or while breastfeeding should only occur if a qualified healthcare provider determines that the potential benefits outweigh the risks. Nicotine exposure can affect fetal development and infant health, so caution is advised.

To place an order, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Nicotine resinate provides nicotine in a salt form, which may offer different absorption characteristics compared with nicotine gums, patches, or lozenges. The choice between products depends on patient preference, dosing flexibility, and clinical judgment regarding efficacy and tolerability.

Store the product at ambient temperature, preferably below 25 °C. Keep it in the original packaging, protect it from moisture and direct sunlight, and ensure the container is tightly closed to maintain product stability.

The product is intended for oral administration. It is typically taken as directed by a healthcare professional, often with water, and should be used according to the prescribed schedule to achieve the desired therapeutic effect.

Serious risks include severe allergic reactions (anaphylaxis), marked hypertension, cardiac arrhythmias, seizures, and persistent vomiting. Patients should seek immediate medical attention if any of these symptoms occur.

Individuals with known hypersensitivity to nicotine or any excipients, those with uncontrolled cardiovascular disease, pregnant or breastfeeding women (unless specifically advised), and patients taking contraindicated medications such as MAO inhibitors should avoid using nicotine resinate.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Nicotine Resinate

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT